Basic and Diluted Net Income (Loss) per Share |
Basic and Diluted Net Income (Loss) per Share Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive shares of common stock been issued. The Company applies the treasury stock method to determine the dilutive effect of potentially dilutive securities.
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
(In thousands, except share and per share data) |
Numerator: |
|
|
|
|
|
|
|
Net income (loss) |
$ |
127,950 |
|
|
$ |
(12,538) |
|
|
$ |
62,608 |
|
|
$ |
(26,086) |
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
184,282,194 |
|
|
16,150,202 |
|
|
183,892,304 |
|
|
16,085,750 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
Common stock options |
18,043,859 |
|
|
— |
|
|
19,130,274 |
|
|
— |
|
Restricted stock units |
— |
|
|
— |
|
|
3,890 |
|
|
— |
|
Diluted weighted average shares outstanding |
202,326,053 |
|
|
16,150,202 |
|
|
203,026,468 |
|
|
16,085,750 |
|
|
|
|
|
|
|
|
|
Net income (loss) per share |
|
|
|
|
|
|
|
Basic |
$ |
0.69 |
|
|
$ |
(0.78) |
|
|
$ |
0.34 |
|
|
$ |
(1.62) |
|
Diluted |
$ |
0.63 |
|
|
$ |
(0.78) |
|
|
$ |
0.31 |
|
|
$ |
(1.62) |
|
The following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation of diluted net income (loss) per share attributable to common stockholders as including them would have had an antidilutive effect:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six months ended June 30, |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|
|
|
|
|
|
|
|
Redeemable convertible preferred stock |
|
— |
|
|
147,876,672 |
|
|
— |
|
|
147,876,672 |
|
Convertible promissory note |
|
— |
|
|
6,756,757 |
|
|
— |
|
|
6,756,757 |
|
Redeemable convertible preferred stock warrants |
|
— |
|
|
408,729 |
|
|
— |
|
|
408,729 |
|
Common stock warrants |
|
13,075,000 |
|
|
293,856 |
|
|
13,075,000 |
|
|
293,856 |
|
Restricted stock units |
|
5,355,860 |
|
|
— |
|
|
5,351,970 |
|
|
— |
|
Common stock options |
|
1,493,147 |
|
|
26,997,994 |
|
|
406,732 |
|
|
26,997,994 |
|
Total potentially dilutive common share equivalents |
|
19,924,007 |
|
|
182,334,008 |
|
|
18,833,702 |
|
|
182,334,008 |
|
Total potentially dilutive common share equivalents for the three and six months ended June 30, 2022, excludes 21,758,148 shares related to the earnout liability as these shares are contingently issuable upon meeting certain triggering events.
|